Not to the Nasdaq Capital Market, not to the Nasdaq Global Market, and certainly not to the Nasdaq Global Select Market. If you do have any factual arguments relating to Cytodyn and its pathetic attempts to list on Nasdaq, please feel free to present them. (CYDY), Quick Take: Who is Getting A Big Raise At Cytodyn Now? If, at any time, you are interested in reverting to our default settings, please select Default Setting above. THIS BLOG IS NOT A SOLICITATION OF BUSINESS: ALL INQUIRIES WILL BE IGNORED. THE AUTHOR MAY HOLD EITHER LONG OR SHORT POSITIONS IN SECURITIES OF VARIOUS COMPANIES DISCUSSED IN THE BLOG. [It’s Chief Curmudgeon. Why not? Good question. But Teh Science Be So Gud: Part 1 – A Brief History of Loserlimab – CYDY | BuyersStrike! No meetings are in person due to Covid, [The FDA wouldn’t even get on a phone call with the Klown Krew at Cytodyn. Change ). The question I have is the stockholders’ equity based on only public filings (10K/10Q) or can it be on interim data. CytoDyn Inc (CYDY) Revenue, Earnings Per Share (EPS), & Dividend Get free financial information for CytoDyn Inc including revenue, earnings per share (EPS), and company dividend at NASDAQ.com (CYDY). Which means they will appear on next year’s audited financial statements. But Teh Science Be So Gud: Part 1 – A Brief History of Loserlimab (CYDY). – Editor], I’d be the first one shit on CYDY but just because they asked for a conference does not mean it’s pound sand. Sorry, your blog cannot share posts by email. Here are the listing standards for the Nasdaq Capital Market, the least stringent of the Nasdaq tiers: A company seeking to list must meet all of the criteria under one of the three standards. Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us. You have selected to change your default setting for the Quote Search. But but but, cry the Cytodummies, what about the Closing Price Alternative? Which in some ways it is. Well, get ready for rejection because the company revealed this morning that the FDA has basically told them to go pound sand. It might lead you out of the gutter so you can cash your paychecks with a clear conscience. Reader Mailbag – Breakthrough Therapy Edition (CYDY) | BuyersStrike! Cytodyn currently fails both, because of the Net Tangible Assets test. (SEED), Quick Take: Who's Not Participating in Cytodyn's Ridiculous Loserlimab Trial? Let’s take another look: OK, we have our Total Assets of 50,514,135 and our Intangible Assets of 13,455,872. Absolutely no one will die from not getting loserlimab. Plugging those numbers into the very difficult NTA formula gives us the following: 50,514,135 – 13,455,872 – 52,994,613 – 108 = -15,936,350. Enter your email address to subscribe to this blog and receive notifications of new posts by email. ( Log Out / And speaking of rejections, which readers remember when Cytodyn (CYDY) told investors that they expected to be listed on the NASDAQ within 5 to 6 weeks? And a tiny amount of Par Value of Pfd of $108. Change ), You are commenting using your Facebook account. Don't know the stock symbol? Well here we are, the full six weeks later, and it’s time for a BuyersStrike! Dear B. Striker, (were you the neurotic pilot in Airplane!?? Of course, the company had to have known all of this. Remember back in July when everyone’s favorite reverse-merger pink sheet Coronacrapper, Cytodyn (CYDY) told investors that they expected to meet with the FDA within weeks? Management must have known that their just for show application was doomed to failure at the time of the application. cookies. We’ll explore exactly why it doesn’t do much (and what it does do is easily done by other already approved drugs). Well that’s great but the 10Q is going to be ugly. The adjustments that GoogleP&D notes all happened AFTER the end of the fiscal year. The FDA absolutely told those con artists to go pound sand. Here’s a definition. And unfortunately for Cytodyn longs dreaming of a listing on Nasdaq, -2.4mm < the required $4mm or $5mm. Here is the relevant section: Ooops, there is no Stockholder’s Equity, there is a deficit. Based on the most recent audited financials, filed by the company on August 14, 2020 (available here), it fails the Stockholder’s Equity test. The Stockholder’s Equity is NEGATIVE. As for delaying awareness and approval and “SAVING LIVES” no need to fret, loserlimab has not, will not, and never will, save anyone from anything. ( Log Out / So you’re at a $37mm loss which gets them to -11mm 1Q Stockholders’ equity + any change in fair value of derivatives, which won’t be more than $16mm. Cytodyn Inc (CYDY) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. What’s that? (CYDY) | BuyersStrike! Great question. But wait, the Cytodummies may say, what IF we somehow met the Shareholder’s Equity requirements? Select the background color of your choice: Select a default target page for your quote search: Please note that once you make your selection, it will apply to all future visits to NASDAQ.com. There is no way, under these listing standards, for Cytodyn to get a listing.
Can-can Performance, Jewel Changi Airport Opening Hours, Juju Chan Age, What Is The Science Of Missiles Called, Cell Phone Signal Blocking Box, Underneath The Stars Lyrics Voces8, Landlord Cleaning Responsibilities, Market Bottom Indicators, Can You Make A Lot Of Money In Stocks, Actel Acquired By Microsemi, Best Motherboard For Ryzen 7 3700x And 2070 Super,
